ReconTop Stories

Exactech Announces New Patent, Strengthening Company’s Position in Joint Replacement Soft Tissue Management

March 23, 2022

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent #11,278,338 for the Newton™ Knee, a dynamic platform of cutting-edge technology used with forward-thinking implants that are designed to provide optimal balance in a reproducible way

“The patent allowance supports the uniqueness of Newton and its ability to maintain a force-controlled environment regardless of the joint gap through antagonist sub-mechanisms,” said Laurent Angibaud, Vice President of Advanced Surgical Technologies at Exactech. “While initially dedicated to total knee arthroplasty, Newton has the potential to be applied to other joints where proper soft tissue management is of paramount importance.”

The patent recognizes Newton’s sophisticated approach to providing critical soft tissue data that helps orthopaedic surgeons execute a total knee replacement with precision. Newton is unique in that it captures active balance data through the entire arc of motion with the patella in place and seamlessly integrates with ExactechGPS® to allow surgeons the ability to visualize a predictive plan through quantifiable insights. This results in a powerful system that is designed for a dynamic, patient-specific and reproducible outcome.

“This recognition is a significant achievement for Exactech,” said Darin Johnson, Exactech President and CEO. “The patent not only protects the commercial potential of the Newton Knee, but it also demonstrates our unwavering commitment to protecting innovation around our entire Active Intelligence® suite of technologies.”

The Newton Knee is in pilot release with limited launch planned for later this year. For more information on Newton and the Active Intelligence portfolio, visit

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit for more information and connect with us on LinkedInVumediYouTubeInstagram and Twitter.


Courtney Adkins,
Marketing Communications Sr. Manager

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button